Related Experiment Videos
[Breast carcinoma staging with sentinel lymphadenectomy]
H K Büchels1, T Wagner, H Vogt
1Klinik für Allgemein- und Viszeralchirurgie, Zentralklinikum Augsburg.
Summary
Sentinel lymph node biopsy (SLNB) accurately stages breast cancer lymph nodes. This method shows promise in reducing axillary dissections and associated patient morbidity.
Area of Science:
- Oncology
- Surgical Pathology
Context:
- Breast cancer staging relies on accurate assessment of regional lymph node involvement.
- Sentinel lymphadenectomy (SLNE) is a technique to identify the first lymph node(s) draining a primary tumor.
- Metastasis to the sentinel node (SLN) predicts involvement of other lymph nodes.
Purpose:
- To evaluate the significance and usefulness of sentinel lymphadenectomy (SLNE) for staging regional lymph nodes in breast cancer patients.
- To assess the correlation between SLN histology and overall axillary specimen status.
Summary:
- The study included 12 patients with operable breast cancer and clinically negative lymph nodes.
- The SLNE method was applicable in 11 out of 12 cases.
- Three sentinel lymph nodes were found to be tumor-positive, with one case showing no correlation between SLN and axillary specimen histology.
Impact:
- Successful implementation of SLNE can potentially reduce the number of formal axillary lymph node dissections.
- Reducing axillary dissections may significantly decrease morbidity in a majority of breast cancer patients.
- This technique offers a more targeted approach to lymph node staging in breast cancer.